Stent thrombosis in acute coronary syndromes: Patient-related factors and operator-related factors.


Journal

Anatolian journal of cardiology
ISSN: 2149-2271
Titre abrégé: Anatol J Cardiol
Pays: Turkey
ID NLM: 101652981

Informations de publication

Date de publication:
10 2020
Historique:
entrez: 1 10 2020
pubmed: 2 10 2020
medline: 3 8 2021
Statut: ppublish

Résumé

Stent thrombosis (ST) is a common phenomenon in acute coronary syndromes (ACS) when compared to stable coronary artery disease. This study analyzed the patient- and operator-related risk factors of ST in ACS. Coronary angiograms of 1738 consecutive ACS patients admitted in a large tertiary center between year 2014 and 2016 were analyzed retrospectively for the presence of ST. The paired angiograms [ST in ACS during and after percutaneous coronary intervention (PCI)] of the patients were analyzed by two independent observers, with focus on lesion characteristics and procedure techniques. Clinical and laboratory data were collected. Stent thrombosis was found in 29 (1.6%) ACS patients, with a combination of at least one clinical/laboratory risk factor and one lesion/operator risk factor identified in 28 (96%) out of the 29 ACS patients with ST. The following risk factors for ST were found: Renal insufficiency (OR=4.14, p<0.001, 95% CI=1.73-9.88), type 2 diabetes (OR=2.21, p=0.034, 95% CI=1.06-4.61), excessive alcohol consumption (OR=3.12, p=0.023, 95% CI=1.17-8.33), stent implantation for ST-elevation myocardial infarction (STEMI) (OR=2.28, p=0.029, 95% CI=1.08-4.81), left main (LM) or left anterior descending artery (LAD) as culprit lesion (OR=2.80, p=0.010, CI 95%=1.27-5.95), and absence of antiplatelet therapy prior to ST (OR=3.58, p=0.002, 95% CI=1.60-7.96). The following lesion/operator possible risk factors were identified: Bifurcation lesion (n=7; 24%), heavy coronary calcifications (n=13; 44%), in-stent restenosis with secondary plate rupture (n=6, 20%), inappropriate stent size selection (n=6, 20%), and errors in periprocedural drug administration (n=4, 14%). ST occurred in 1/62 ACS patients after PCI. A combination of clinical/laboratory and lesion/operator risk factors were present in almost all ACS patients with ST. This finding may support the search for strictly individualized strategies for the treatment of ACS patients with ST after PCI.

Identifiants

pubmed: 33001053
doi: 10.14744/AnatolJCardiol.2020.69679
pmc: PMC7585955
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

274-279

Références

EuroIntervention. 2010 Dec;6 Suppl J:J107-11
pubmed: 21930473
Am J Cardiol. 2014 Jun 1;113(11):1794-801
pubmed: 24837256
Heart. 2004 Oct;90(10):1189-93
pubmed: 15367521
Eur Heart J Cardiovasc Pharmacother. 2019 Apr 1;5(2):105-116
pubmed: 30285099
Circ Cardiovasc Interv. 2019 Jun;12(6):e007822
pubmed: 31177822
Catheter Cardiovasc Interv. 2018 Apr 1;91(5):849-850
pubmed: 29634861
Am Heart J. 1999 Jan;137(1):93-9
pubmed: 9878940
J Interv Cardiol. 2013 Aug;26(4):325-31
pubmed: 23941650
JAMA. 2005 May 4;293(17):2126-30
pubmed: 15870416
Int J Cardiol. 2013 Jul 31;167(2):575-84
pubmed: 22360945
Am J Cardiol. 2018 Nov 15;122(10):1638-1646
pubmed: 30270177
Catheter Cardiovasc Interv. 2003 Jun;59(2):184-92
pubmed: 12772236
Catheter Cardiovasc Interv. 2015 Jan 1;85(1):1-10
pubmed: 24408084
J Am Coll Cardiol. 2018 Apr 17;71(15):1676-1695
pubmed: 29650125
Cardiology. 2017;137(4):246-255
pubmed: 28472800
JACC Cardiovasc Interv. 2009 Jun;2(6):534-41
pubmed: 19539258
Clin Appl Thromb Hemost. 2010 Feb;16(1):33-41
pubmed: 19736213
J Am Coll Cardiol. 2006 Jul 4;48(1):193-202
pubmed: 16814667
Am J Cardiol. 2016 May 15;117(10):1562-1568
pubmed: 27020664
Circulation. 2007 May 1;115(17):2344-51
pubmed: 17470709
Lancet. 2007 Feb 24;369(9562):667-78
pubmed: 17321312
Circulation. 2007 Feb 27;115(8):1051-8
pubmed: 17325255
JACC Cardiovasc Interv. 2014 Oct;7(10):1081-92
pubmed: 25341705
Am Heart J. 2010 Apr;159(4):672-6
pubmed: 20362728
N Engl J Med. 1987 Mar 19;316(12):701-6
pubmed: 2950322
JACC Cardiovasc Interv. 2013 Nov;6(11):1176-83
pubmed: 24262618
J Am Coll Cardiol. 2010 Oct 19;56(17):1357-65
pubmed: 20946992
Int J Cardiol. 2016 Nov 1;222:185-194
pubmed: 27497093
World J Cardiol. 2016 Dec 26;8(12):728-734
pubmed: 28070240
Circulation. 2001 Apr 17;103(15):1967-71
pubmed: 11306525
Heart Vessels. 2013 Jul;28(4):424-33
pubmed: 22975713
JACC Cardiovasc Interv. 2013 Dec;6(12):1267-74
pubmed: 24355117
J Thromb Haemost. 2010 Nov;8(11):2385-93
pubmed: 20831622
Circulation. 2010 Sep 14;122(11):1077-84
pubmed: 20805433
J Interv Cardiol. 2018 Apr;31(2):159-169
pubmed: 29468725
Int J Cardiol. 2018 Jul 15;263:9-16
pubmed: 29754928
JACC Cardiovasc Interv. 2015 Jan;8(1 Pt B):214-220
pubmed: 25616927

Auteurs

Martin Kamenik (M)

Cardiocenter, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady; Prague-Czech Republic.

Petr Widimsky (P)

Cardiocenter, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady; Prague-Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH